Cargando…

266. Implementation and Evaluation of a Pharmacist-Managed Pediatric Vancomycin Protocol

BACKGROUND: Pediatric studies have shown that pharmacist-guided vancomycin dosing leads to reduction in time to initial target vancomycin trough, duration of vancomycin therapy, time to clinical stability, and shorter hospital stay. At Boston Medical Center, 65% of pediatric patients receiving vanco...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vu, Christine, Brade, Karrine, Farrell, Camilla, Mancuso, Michelle
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6255126/ http://dx.doi.org/10.1093/ofid/ofy210.277

Ejemplares similares

103. Expansion of an Antimicrobial Stewardship Program Through Implementation of a Discharge Verification Queue
por: Rubin, Ellen C, et al.
Publicado: (2021)

442. Risk Score for Vancomycin-Associated Acute Kidney Injury in Hospitalized Patients with Acute Bacterial Skin and Skin Structure Infections
por: Jorgensen, Sarah C J, et al.
Publicado: (2019)

197. Implementation of a Prospective, Pharmacist-Led Methicillin-Resistant Staphylococcus aureus Nasal PCR Screening Pilot Protocol to Reduce Overutilization of Vancomycin
por: Miller, Jessica, et al.
Publicado: (2018)

756. Impact of Infectious Diseases Pharmacists as Part of an Interdisciplinary OPAT Team Managing Vancomycin
por: Adamsick, Meagan L, et al.
Publicado: (2019)

1209. Let’s take a time-out: Implementing a standardized process to assess the clinical use of vancomycin for pharmacists
por: Oderinde, Jennifer, et al.
Publicado: (2023)

113. Improving Transitions-of-Care for Patients Discharged on High-Risk Antimicrobial Therapy
por: Zabrosky, Ryan, et al.
Publicado: (2021)

Hypermobility: a Key Factor in Hip Dysplasia. A Prospective Evaluation of 266 Patients.
por: Muldoon, Michael, et al.
Publicado: (2016)

275. Evaluation of Vancomycin Prescribing Quality in Hospitalized Pediatric Patients
por: Abanyie-Bimbo, Francisca, et al.
Publicado: (2018)

266 Dalbavancin vs Vancomycin for the treatment of acute bacterial skin and skin structure infections (ABSSSI): a subanalysis from the DISCOVER studies
por: Puttagunta, Sailaja, et al.
Publicado: (2014)

610. Low Rates of Acute Kidney Injury (AKI) in Outpatient Vancomycin Managed by Pharmacists using Precision Dosing Software
por: Schroeder, Claudia P, et al.
Publicado: (2022)

The Development, Implementation, and Evaluation of a Pharmacist-Managed Therapeutic Drug Monitoring (TDM) Service for Vancomycin—A Pilot Study
por: Firman, Paul, et al.
Publicado: (2022)

182. Missed Opportunities to Discontinue Unnecessary Vancomycin During Pharmacist Therapeutic Monitoring
por: Medler, Corey J, et al.
Publicado: (2020)

Oritavancin: A New Lipoglycopeptide Antibiotic in the Treatment of Gram-Positive Infections
por: Brade, Karrine D., et al.
Publicado: (2016)

266. Cumulative Steroid Dose in Hospitalized Patients and COVID-19 Associated Pulmonary Aspergillosis
por: Ramonfaur, Diego, et al.
Publicado: (2022)

Impact of Vancomycin Serum Trough Concentrations and Vancomycin AUC/MIC on Vancomycin Response, In-Hospital Outcomes and Acute Kidney Injury in Pediatric Staphylococcus aureus Pneumonia
por: McNeil, Jonathon, et al.
Publicado: (2017)

1911. Implementation of Diabetes Medication Management by Pharmacists in a Multidisciplinary Limb-Salvage Clinic
por: Rockstad, Molly, et al.
Publicado: (2018)

1415. Implementation and Validation of a Vancomycin AUC/MIC Calculator and Dosing Protocol at a Large Community Hospital
por: Seddon, Megan, et al.
Publicado: (2018)

901. Evaluation of Azithromycin Usage Following a Pharmacist Discontinuation Protocol
por: Percival, Kelly M, et al.
Publicado: (2022)

Implementation of a Vancomycin AUC Monitoring Program: Peaks and Pitfalls
por: Kassamali, Zahra, et al.
Publicado: (2017)

Enhancing Antibiotic Stewardship Team (AST) Efforts in Decreasing Inappropriate Vancomycin Usage in Neutropenic Fever (NF) Patients through Unit Based Pharmacist Intervention
por: Perreault, Sarah, et al.
Publicado: (2017)

266. Ceftriaxone Versus Cefazolin for the Treatment of Methicillin-Susceptible Staphylococcus aureus Bacteremia
por: Mohamed, Adham, et al.
Publicado: (2020)

1489. Safety and Performance of a Pharmacist-Driven Nasal MRSA PCR Protocol for De-escalation of Empiric Vancomycin for Suspected Pneumonia at an Academic Medical Center
por: Meng, Lina, et al.
Publicado: (2020)

1274. Implementation of Pharmacist-led Medication Reconciliation in Older PLHIV
por: Karris, Maile Y, et al.
Publicado: (2022)

P30 Evaluating vancomycin continuous infusion protocol compliance and gauging therapeutic target attainment in neonates
por: Lewis, Francesca, et al.
Publicado: (2023)

PS266. North Korean female refugees' quality of life: Influence of Physical Health, PTSD, and Social Support
por: Lee, So Hee
Publicado: (2016)

1068. Implementation of an Antimicrobial Stewardship Program (ASP) Managed by an Infectious Disease Physician and Pharmacists in a Community Hospital
por: Brady PharmD, Jeanne, et al.
Publicado: (2019)

A Multicenter Evaluation of Vancomycin-Associated Acute Kidney Injury in Hospitalized Patients with Acute Bacterial Skin and Skin Structure Infections
por: Jorgensen, Sarah C. J., et al.
Publicado: (2020)

2322. Reduced Vancomycin Susceptibility Among Pediatric Staphylococcus aureus Bloodstream Infections
por: Ericson, Jessica, et al.
Publicado: (2018)

2332. Higher Pediatric Vancomycin Dosing Trends Toward Improved Therapeutic Troughs
por: Boeglin, August, et al.
Publicado: (2018)

1130. Vancomycin Use in Pediatric Severe Sepsis at a Freestanding Children’s Hospital
por: Islam, Shamim M, et al.
Publicado: (2019)

136. Factors Associated with Reduced Vancomycin Susceptibility in Pediatric Staphylococcus aureus Bacteremia
por: Ericson, Jessica E, et al.
Publicado: (2019)

1571. Evaluation of a Single Post First Dose Vancomycin Level to Achieve a Goal Vancomycin AUC
por: Hurley, Evan, et al.
Publicado: (2019)

266. Clinical Profile and Treatment Outcomes of Candida auris Isolates from a Tertiary Care Hospital in South India
por: Warrier, Anup R, et al.
Publicado: (2019)

959. It Takes a Village: Reducing Empiric Vancomycin Use by Leveraging Primary Team Pharmacist Oversight of a 72-hour Approval Process
por: Pettit, Natasha N, et al.
Publicado: (2022)

266. A Rare Case of Human Herpesvirus-6 (HHV-6) Encephalitis in an Immunocompetent Host
por: Ayyash, Ali M, et al.
Publicado: (2021)

Pharmacist-directed vancomycin therapeutic drug monitoring in pediatric patients: a collaborative-practice model
por: Hussain, Kashif, et al.
Publicado: (2021)

1223. Utilizing Multiple Antimicrobial Stewardship Metrics to Trend Vancomycin Use in an Implementation Study
por: Wolfe, Kaleb H, et al.
Publicado: (2023)

666. Evaluation of Vancomycin Harms for Intra-abdominal Infections
por: McCoy, Christopher, et al.
Publicado: (2023)

1572. Evaluation of Vancomycin Levels Following Weight-Based Pre-operative and Re-warming Vancomycin Dosing in Cardiac Surgery
por: Ruggero, Michael, et al.
Publicado: (2019)

1645. Predicting Vancomycin Area Under the Curve by Bayesian-Guided Dosing in Pediatric Patients
por: Shin, Donghyun, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8k89nosc9d75du5b9q7efsj2jp